Intervention

BGJ398

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions8

Lead sponsors shown1

Clinical trials

2 shown

Phase 1b Trial of BGJ398/BYL719 in Solid TumorsNCT01928459 · 2013-10-01

A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesNCT01004224 · 2009-12-11

Common conditions

Advanced Solid Tumors1 Advanced Solid Tumors With Alterations of FGFR1, 2 and or 31 Advanced Solid Tumors With FGFR1 Amplication1 Advanced Solid Tumors With FGFR2 Amplication1 Advanced Solid Tumors With FGFR3 Mutation1 Bladder Cancer With FGFR3 Mutation or Fusion1 Metastatic Solid Tumors1 Squamous Lung Cancer With FGFR1 Amplification1

Leading sponsors

Novartis Pharmaceuticals2

Trial status mix

COMPLETED2

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.